Image

Middle East and Africa Health Screening Market – Industry Trends and Forecast to 2028

Healthcare

Image

Middle East and Africa Health Screening Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Oct 2021
  • MEA
  • 350 Pages
  • No of Tables: 219
  • No of Figures: 57

Middle East and Africa Health Screening Market, By Test Type (Cholesterol Tests, Diabetes Test, Cancer Screening, General Check Up Test, STDs, Blood Pressure Test and Others), Package Type (Basic Health Screening, Senior Citizen Profile, Women Health Check, Men Health Check, Heart Check, Diabetes Check and Others), Panel Type (Multi-Test Panels and Single-Test Panels), Sample Type (Blood, Urine, Serum, Saliva and Others), Technology (Immunoassays, Medical Imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in Situ Hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis) and Others), Condition (Cardiovascular Disease, Metabolic Disorders, Cancer, Inflammatory Conditions, Musculoskeletal Disorders, Neurological Conditions, Hepatitis-C Complications, Immunology-Related Conditions and Others), Sample Collection Sites (Hospital, Homes, Diagnostic Laboratories, Offices and Others), Distribution Channel (Direct Tenders, Retail Sales and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel and Rest of the Middle East and Africa) Industry Trends and Forecast to 2028.

Middle East and Africa Health Screening Market Market Analysis and Insights: Middle East and Africa Health Screening Market

Middle East and Africa health screening market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.8% in the forecast period of 2021 to 2028 and is expected to reach USD 9,344.91 million by 2028. The rising number of chronic diseases, geriatric population, and increasing awareness about early detection and treatment of disease are the major drivers that propelled the market's demand in the forecast period.

Health screening is an important method of early detection of a specific disorder. The screening tests are often used in preventative medicine to identify whether an individual shows early signs of a condition's risk factors. The disease, which may be detected by screening includes cancer, diabetes, high cholesterol, high blood pressure, and osteoporosis. A surge in the volume of chronic disease, geriatric population, increasing awareness about early detection and treatment of disease is propelling the growth of the health screening market.

The rising awareness among people about early detection and treatment of disease and increasing health expenditure are increasing the demand for health screening.

Rising demand for health screening because of its efficacy, growing number of service providers, and increasing awareness campaign by private and public players of health screening are propelling the growth of the health screening market in the forecast period by acting as opportunity. However, the high cost of screening test may hamper the market growth in the forecast period.

Middle East and Africa health screening market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.

Middle East and Africa Health Screening Market Middle East and Africa Health Screening Market Scope and Market Size

Middle East and Africa health screening market is segmented into eight notable segments based on test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of test type, the Middle East and Africa health screening market is segmented into cholesterol tests, diabetes test, cancer screening, general checkup test, STDs, blood pressure test, and others. In 2021, cholesterol test segment is expected to dominate the market because this test is common and the cholesterol level can be easily measured in less infrastructure and medical facilities.
  • On the basis of package type, the Middle East and Africa health screening market is segmented into basic health screening, senior citizen profile, women health check, men health check, heart check, diabetes check, and others. In 2021, basic health screening segment is expected to dominate the market because of increasing awareness among people and initiatives by global bodies to implement heath camps and an average healthcare facility in these regions
  • On the basis of panel type, the Middle East and Africa health screening market is segmented into multi-test panels and single-test panels. In 2021, multi-test panels segment is expected to dominate the market as the disease rate is high in this region especially in Africa which increase the demand for multi-panel test in the forecasted period.
  • On the basis of sample type, the Middle East and Africa health screening market is segmented into blood, urine, serum, saliva, and others. In 2021, blood segment is expected to dominate the market because blood test can help identify how well the organs are working such as heart, kidneys, and liver among others.
  • On the basis of technology, the Middle East and Africa health screening market is segmented into immunoassays, medical imaging, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, in situ hybridization), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis), and others. In 2021, immunoassays segment is expected to dominate the market because immunoassays are contributing in various applications including blood transfusions, gene therapies, implant operations, screening of infectious diseases and others. Increasing number of surgeries, infectious diseases, and gene therapies are driving the growth of the immunoassays segment.
  • On the basis of condition, the Middle East and Africa health screening market is segmented into cardiovascular disease, metabolic disorders, cancer, inflammatory conditions, musculoskeletal disorders, neurological conditions, hepatitis-C complications, immunology-related conditions, and others. In 2021, cardiovascular disease segment is expected to dominate the market the disease has a high prevalence and incidence in almost every country around the world and increase obesity and lack of nutrition can also propel the disease incidence
  • On the basis of sample collection sites, the Middle East and Africa health screening market is segmented into hospitals, homes, diagnostic laboratories, offices, and others. In 2021, hospitals segment is expected to dominate the market as the funding from global agencies in African Region to develop hospital has increased which is driving the hospital segment in Middle East & Africa Region
  • On the basis of distribution channel, the Middle East and Africa health screening market is segmented into direct tenders, retail sales, and others. In 2021, direct tender segment is expected to dominate the market because of increasing presence of companies in these region as African region is highly susceptible to new diseases

Middle East and Africa Health Screening Market Country Level Analysis

Middle East and Africa health screening market is analyzed, and market size information is provided on the test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel.

The countries covered in the Middle East and Africa health screening market are Saudi Arabia, South Africa, Egypt, the Rest of the Middle East and Africa. South Africa in the Middle East and Africa region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 as it is an emerging market which is having huge potential to support health screening market in growing.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the Middle East and African brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Middle East and Africa Health Screening Market are boosting the Market Growth

The Middle East and Africa health screening treatment market also provides you with detailed market analysis for every country's growth in the screening services industry with drugs sales, the impact of advancement, technology, and changes in regulatory scenarios with their support for the health screening treatment market. The data is available for the historic period 2010 to 2019.

Competitive Landscape and Middle East and Africa Health Screening Market Share Analysis

Middle East and Africa health screening market competitive landscape provide details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the Middle East and Africa health screening market.

The major companies operating in the Quest Diagnostics Incorporated, GRAIL, Eurofins Scientific, Exact Sciences Corporation, SYNLAB International GmbH, UNILABS, LabPLUS, BioReference Laboratories, Sonic Healthcare Limited, ACM Global Laboratories, Cerba Healthcare, Quidel Corporation, Innova Medical Group, AMEDES Holding GmbH, RadNet, Inc., Natera, Inc., Trinity Biotech, Nuffield Health, RepeatDx, NeoGenomics Laboratories, H.U Group Holdings, Inc., Lifelabs, ARUP Laboratories, Q2 Solutions, Genova Diagnostics, Life Length, DNA Labs India, Healius Limited, Telomere Diagnostics, Charles River Laboratories, Ambry Genetics, SpectraCell Laboratories, Inc., Dr. Lal PathLabs, and Laboratory Corporation of America among others.

Many events, agreements, and webinars are also initiated by the companies worldwide, which also accelerates the Middle East and Africa health screening market.

For instances,

  • In June 2018, ACM Global Laboratories announced that it has developed Smarter Testing for Oncology to deliver a unique service offering for their clients conducting cancer research. This has increased the company’s customer engagement.

Collaboration, product launch, business expansion, award and recognition, joint ventures, and other strategies by the market player enhance the company market in the Middle East and Africa health screening market, which also benefits the organization to improve their offering health screening services.


SKU-

TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)

TABLE 2 NEW CANCER CASES FOR AGE 85+ IN U.S.

TABLE 3 ACCORDING TO THE UNITED NATIONS, IN 2019, THE TOTAL POPULATION OF AGED PEOPLE ABOVE 65 WAS 703 MILLION AND IS EXPECTED TO REACH 1.5 BILLION BY 2050.

TABLE 4 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)

TABLE 5 MIDDLE EAST & AFRICA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA DIABETES TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA CANCER SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA STD’S IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA STD’S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA BLOOD PRESSURE TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA MULTI-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA BASIC HEALTH SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA SENIOR CITIZEN PROFILE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA WOMEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA MEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA HEART CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA DIABETES CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA BLOOD IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA URINE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA SERUM IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA SALIVA IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA IMMUNOASSAYS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA MEDICAL IMAGING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA QPCR IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA Q-FISH IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA Q-FISH IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA TRF (TERMINAL RESTRICTION FRAGMENT) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA STELA (SINGLE TELOMERE LENGTH ANALYSIS) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 53 MIDDLE EAST & AFRICA CANCER IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 54 MIDDLE EAST & AFRICA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 55 MIDDLE EAST & AFRICA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 56 MIDDLE EAST & AFRICA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 57 MIDDLE EAST & AFRICA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 58 MIDDLE EAST & AFRICA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 59 MIDDLE EAST & AFRICA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 60 MIDDLE EAST & AFRICA IMMUNOLOGY-RELATED CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 61 MIDDLE EAST & AFRICA HEPATITIS-C COMPLICATIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 62 MIDDLE EAST & AFRICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 63 MIDDLE EAST & AFRICA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 64 MIDDLE EAST & AFRICA DIRECT TENDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 65 MIDDLE EAST & AFRICA RETAIL SALES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 66 MIDDLE EAST & AFRICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 67 MIDDLE EAST & AFRICA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 68 MIDDLE EAST & AFRICA HOSPITAL IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 69 MIDDLE EAST & AFRICA HOSPITAL IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 70 MIDDLE EAST & AFRICA HOME IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 71 MIDDLE EAST & AFRICA DIAGNOSTIC LABORATORIES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 72 MIDDLE EAST & AFRICA OFFICES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 73 MIDDLE EAST & AFRICA OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 74 MIDDLE EAST AND AFRICA HEALTH SCREENING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 75 MIDDLE EAST AND AFRICA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 76 MIDDLE EAST AND AFRICA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 77 MIDDLE EAST AND AFRICA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 78 MIDDLE EAST AND AFRICA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 79 MIDDLE EAST AND AFRICA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 80 MIDDLE EAST AND AFRICA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 81 MIDDLE EAST AND AFRICA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 82 MIDDLE EAST AND AFRICA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 83 MIDDLE EAST AND AFRICA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 84 MIDDLE EAST AND AFRICA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 85 MIDDLE EAST AND AFRICA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 86 MIDDLE EAST AND AFRICA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 87 MIDDLE EAST AND AFRICA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 88 MIDDLE EAST AND AFRICA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 89 MIDDLE EAST AND AFRICA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 90 MIDDLE EAST AND AFRICA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 91 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 92 MIDDLE EAST AND AFRICA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 93 MIDDLE EAST AND AFRICA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 94 MIDDLE EAST AND AFRICA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 95 MIDDLE EAST AND AFRICA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 96 MIDDLE EAST AND AFRICA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 97 MIDDLE EAST AND AFRICA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 98 MIDDLE EAST AND AFRICA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 99 SAUDI ARABIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 100 SAUDI ARABIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 101 SAUDI ARABIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 102 SAUDI ARABIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 103 SAUDI ARABIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 104 SAUDI ARABIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 105 SAUDI ARABIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 106 SAUDI ARABIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 107 SAUDI ARABIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 108 SAUDI ARABIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 109 SAUDI ARABIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 110 SAUDI ARABIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 111 SAUDI ARABIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 112 SAUDI ARABIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 113 SAUDI ARABIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 114 SAUDI ARABIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 115 SAUDI ARABIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 116 SAUDI ARABIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 117 SAUDI ARABIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 118 SAUDI ARABIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 119 SAUDI ARABIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 120 SAUDI ARABIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 121 SAUDI ARABIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 122 SAUDI ARABIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 123 SOUTH AFRICA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 124 SOUTH AFRICA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 125 SOUTH AFRICA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 126 SOUTH AFRICA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 127 SOUTH AFRICA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 128 SOUTH AFRICA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 129 SOUTH AFRICA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 130 SOUTH AFRICA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 131 SOUTH AFRICA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 132 SOUTH AFRICA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 133 SOUTH AFRICA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 134 SOUTH AFRICA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 135 SOUTH AFRICA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 136 SOUTH AFRICA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 137 SOUTH AFRICA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 138 SOUTH AFRICA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 139 SOUTH AFRICA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 140 SOUTH AFRICA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 141 SOUTH AFRICA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 142 SOUTH AFRICA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 143 SOUTH AFRICA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 144 SOUTH AFRICA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 145 SOUTH AFRICA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 146 SOUTH AFRICA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 147 U.A.E HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 148 U.A.E CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 149 U.A.E DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 150 U.A.E CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 151 U.A.E GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 152 U.A.E REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 153 U.A.E STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 154 U.A.E OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 155 U.A.E HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 156 U.A.E HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 157 U.A.E SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 158 U.A.E HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 159 U.A.E HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 160 U.A.E QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 161 U.A.E Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 162 U.A.E HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 163 U.A.E CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 164 U.A.E METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 165 U.A.E INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 166 U.A.E MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 167 U.A.E NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 168 U.A.E HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 169 U.A.E HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 170 U.A.E HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 171 EGYPT HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 172 EGYPT CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 173 EGYPT DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 174 EGYPTCANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 175 EGYPT GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 176 EGYPT REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 177 EGYPT STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 178 EGYPT OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 179 EGYPT HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 180 EGYPT HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 181 EGYPT SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 182 EGYPT HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 183 EGYPT HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 184 EGYPT QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 185 EGYPT Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 186 EGYPT HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 187 EGYPT CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 188 EGYPT METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 189 EGYPT INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 190 EGYPT MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 191 EGYPT NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 192 EGYPT HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 193 EGYPT HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 194 EGYPT HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 195 ISRAEL HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 196 ISRAEL CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 197 ISRAEL DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 198 ISRAEL CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 199 ISRAEL GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 200 ISRAEL REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 201 ISRAEL STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 202 ISRAEL OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 203 ISRAEL HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 204 ISRAEL HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 205 ISRAEL SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 206 ISRAEL HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 207 ISRAEL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 208 ISRAEL QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 209 ISRAEL Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 210 ISRAEL HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 211 ISRAEL CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 212 ISRAEL METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 213 ISRAEL INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 214 ISRAEL MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 215 ISRAEL NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 216 ISRAEL HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 217 ISRAEL HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 218 ISRAEL HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 219 REST OF MIDDLE EAST & AFRICA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials